{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:50:19Z","timestamp":1793303419884,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1111\/jth.15741","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T04:00:26Z","timestamp":1650859226000},"page":"1674-1683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3810-2008","authenticated-orcid":false,"given":"Melanie","family":"Demers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kistanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0378-0909","authenticated-orcid":false,"given":"Ekta","family":"Seth Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15741_bb0010","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3324\/haematol.2014.116863","article-title":"Rate\u2010limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet\u2010fibrin thrombi under flow","volume":"100","author":"Swieringa","year":"2015","journal-title":"Haematologica"},{"key":"10.1111\/jth.15741_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1111\/jth.15741_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1160\/TH13-06-0479","article-title":"Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand","volume":"111","author":"Antovic","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15741_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078732","article-title":"The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models","volume":"8","author":"Onasoga\u2010Jarvis","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 6","key":"10.1111\/jth.15741_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15741_bb0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-3-030-41769-7_18","article-title":"Physiological roles of the von Willebrand Factor\u2010Factor VIII interaction","volume":"94","author":"Kiouptsi","year":"2020","journal-title":"Subcell Biochem"},{"key":"10.1111\/jth.15741_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15741_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease","volume":"60","author":"Weiss","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.15741_bb0050","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1016\/S0021-9258(18)54729-3","article-title":"The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII","volume":"266","author":"Wise","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15741_bb0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/17474086.2019.1645002","article-title":"Pharmacokinetic and safety considerations when switching from standard to extended half\u2010life clotting factor concentrates in hemophilia","volume":"12","author":"Morfini","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1111\/jth.15741_bb0060","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII\u2010VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0065","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/bloodadvances.2021006119","article-title":"Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat\u2010dose study","volume":"6","author":"Lissitchkov","year":"2022","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15741_bb0070","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood.2019001292","article-title":"BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice","volume":"135","author":"Seth Chhabra","year":"2020","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0075","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/blood-2018-10-876300","article-title":"The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis","volume":"133","author":"Dong","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0080","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1042\/BCJ20180431","article-title":"The D\u2019 domain of von Willebrand factor requires the presence of the D3 domain for optimal factor VIII binding","volume":"475","author":"Przeradzka","year":"2018","journal-title":"Biochem J"},{"key":"10.1111\/jth.15741_bb0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2015.10.038","article-title":"Extension of in vivo half\u2010life of biologically active molecules by XTEN protein polymers","volume":"240","author":"Podust","year":"2016","journal-title":"J Control Release"},{"key":"10.1111\/jth.15741_bb0095","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nbt.1588","article-title":"A recombinant polypeptide extends the in vivo half\u2010life of peptides and proteins in a tunable manner","volume":"27","author":"Schellenberger","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1111\/jth.15741_bb0100","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.2020009197","article-title":"Molecular determinants of the factor VIII\/von Willebrand factor complex revealed by BIVV001 cryo\u2010electron microscopy","volume":"137","author":"Fuller","year":"2021","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood-2018-01-829523","article-title":"A factor VIII\u2010nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation","volume":"132","author":"Muczynski","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0110","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa2002699","article-title":"BIVV001 fusion protein as factor VIII replacement therapy for hemophilia A","volume":"383","author":"Konkle","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15741_bb0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jth.12802","article-title":"Novel mouse hemostasis model for real\u2010time determination of bleeding time and hemostatic plug composition","volume":"13","author":"Getz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15741_bb0120","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.15741_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.15872","article-title":"Advances in understanding the molecular mechanisms that maintain normal haemostasis","volume":"186","author":"O'Donnell","year":"2019","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15741","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15741","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622019328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622019328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:35:12Z","timestamp":1761536112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622019328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1538783622019328"],"URL":"https:\/\/doi.org\/10.1111\/jth.15741","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}